Safety Considerations and Side Effect Monitoring in Adolescents Nausea, constipation, and reduced appetite are common early side effects of GLP-1 and GIP agonists in all age groups
Semaglutide belongs to a class of medications known as peptide-based drugs
However, metabolic adaptation means your effective dose relative to your current body weight actually decreases as you lose pounds
Inside the body, oxidation damage, called oxidative stress, causes damage to the proteins that keep the cells and their membranes running
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Our immunometabolism MS service extends this into dedicated immune cell metabolic profiling contexts
